Overview
Katarzyna Tyrak practices practicing medicine in Krakow, Poland.
Her clinical expertise encompasses Familial Atypical Multiple Mole Melanoma Syndrome, Asthma, and Breast Cancer.
She is actively involved in clinical research, co-authoring 21 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Katarzyna E. Tyrak
Is Katarzyna E. Tyrak a top-rated expert for Familial Atypical Multiple Mole Melanoma Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Katarzyna E. Tyrak is classified as an Experienced expert for Familial Atypical Multiple Mole Melanoma Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Katarzyna E. Tyrak participate in research or clinical trials?
Yes. Katarzyna E. Tyrak has published 21 articles and abstracts on conditions like Familial Atypical Multiple Mole Melanoma Syndrome. You can view a list of Katarzyna E. Tyrak's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AsthmaMs. Tyrak isExperienced. Learn about Asthma.
- Breast CancerMs. Tyrak isExperienced. Learn about Breast Cancer.
- Familial Atypical Multiple Mole Melanoma Syndrome